Women, aspirin & cancer
This article was originally published in The Tan Sheet
Executive Summary
"Extended aspirin use may be associated with significantly increased cancer risk among women," Eva Schernhammer, MD, Harvard University Medical School, et al., reported at a meeting of the American Association for Cancer Research in Phoenix Oct. 26-30. Among 88,378 participants in the Nurses' Health Study, researchers identified 161 cases of pancreatic cancer in previously cancer-free individuals. The risk increased 58% for women who took aspirin twice a week or more for more than 20 years. "These findings, if confirmed, add another variable to the complex risk-benefit profile of aspirin," Schernhammer cautioned...